RAD51 Gene Mutation clinical trials at University of California Health
2 in progress, 1 open to eligible people
Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects
open to eligible males ages 18 years and up
This phase II trial studies how well niraparib, when given before surgery, works in treating patients with high risk prostate cancer that has not spread to other parts of the body (localized) and alterations in deoxyribonucleic acid (DNA) repair…
at UC Davis
Olaparib in Metastatic Breast Cancer
Sorry, in progress, not accepting new patients
This research study is for patients with metastatic breast cancer. - Metastatic means that the cancer has spread beyond the breast. In addition, through genetic testing of the blood or tumor, an altered gene has been found that suggests the tumor…
at UCSF
Our lead scientists for RAD51 Gene Mutation research studies include Michelle Melisko.
Last updated: